DE69934902D1 - Medikament gegen drogenabhängigkeit - Google Patents

Medikament gegen drogenabhängigkeit

Info

Publication number
DE69934902D1
DE69934902D1 DE69934902T DE69934902T DE69934902D1 DE 69934902 D1 DE69934902 D1 DE 69934902D1 DE 69934902 T DE69934902 T DE 69934902T DE 69934902 T DE69934902 T DE 69934902T DE 69934902 D1 DE69934902 D1 DE 69934902D1
Authority
DE
Germany
Prior art keywords
drug dependence
against drug
medicament against
medicament
dependence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934902T
Other languages
English (en)
Other versions
DE69934902T2 (de
Inventor
Tsutomu Suzuki
Shiro Mita
Kiyoshi Matsuno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE69934902D1 publication Critical patent/DE69934902D1/de
Publication of DE69934902T2 publication Critical patent/DE69934902T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69934902T 1998-11-09 1999-11-04 Medikament gegen drogenabhängigkeit Expired - Lifetime DE69934902T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP31746898 1998-11-09
JP31746898 1998-11-09
PCT/JP1999/006148 WO2000027833A1 (fr) 1998-11-09 1999-11-04 Medicaments contre la dependance aux drogues

Publications (2)

Publication Number Publication Date
DE69934902D1 true DE69934902D1 (de) 2007-03-08
DE69934902T2 DE69934902T2 (de) 2007-10-18

Family

ID=18088576

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934902T Expired - Lifetime DE69934902T2 (de) 1998-11-09 1999-11-04 Medikament gegen drogenabhängigkeit

Country Status (9)

Country Link
US (1) US6492369B2 (de)
EP (1) EP1130018B1 (de)
KR (1) KR100700347B1 (de)
CN (1) CN1131221C (de)
CA (1) CA2349452C (de)
DE (1) DE69934902T2 (de)
ES (1) ES2281196T3 (de)
NO (1) NO321735B1 (de)
WO (1) WO2000027833A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2116539A1 (de) 2008-04-25 2009-11-11 Laboratorios Del. Dr. Esteve, S.A. 1-Aryl-3-Amino-alkoxy-pyrazole als Sigma-Liganden zur Verbesserung der analgetischen Wirkung von Opioiden und zur Schwächung der Abhängigkeit davon
EP2353591A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Verstärkung der analgesischen Wirkung von Opioden und Opiaten bei postoperativem Schmerz und zur Schwächung der Abhängigkeit davon
EP2353598A1 (de) 2010-02-04 2011-08-10 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Anwendung in der Vorbeugung und/oder Behandlung von postoperativem Schmerz
EP2388005A1 (de) 2010-05-21 2011-11-23 Laboratorios Del. Dr. Esteve, S.A. Sigma-Liganden zur Vorbeugung und/oder Behandlung von Erbrechen infolge von Chemotherapie oder Strahlentherapie
EP2415471A1 (de) 2010-08-03 2012-02-08 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei opioidinduzierter Hyperalgesie
EP2524694A1 (de) 2011-05-19 2012-11-21 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Sigmaliganden bei Schmerz im Zusammenhang mit Typ-2-Diabetes
AU2014364647A1 (en) 2013-12-17 2016-06-23 Laboratorios Del Dr. Esteve, S.A. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) and Sigma receptor ligands combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5556857A (en) * 1991-05-08 1996-09-17 Otsuka Pharmaceutical Co., Ltd. Disturbance-of-consciousness improving agent
JPH06509069A (ja) * 1991-06-27 1994-10-13 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンドおよびその用途
EP0714292A4 (de) * 1993-06-23 1996-10-09 Cambridge Neuroscience Inc Sigma-rezeptor-liganden und ihre verwendung
ATE197047T1 (de) * 1993-07-28 2000-11-15 Santen Pharmaceutical Co Ltd 1,4-di(phenylalkyl)piperazinderivate
JP2883970B2 (ja) 1993-07-28 1999-04-19 参天製薬株式会社 新規１，４−（ジフェニルアルキル）ピペラジン誘導体
JPH10120569A (ja) 1996-10-21 1998-05-12 Santen Pharmaceut Co Ltd 眼疾患予防または治療剤

Also Published As

Publication number Publication date
KR100700347B1 (ko) 2007-03-29
EP1130018A4 (de) 2003-01-15
US6492369B2 (en) 2002-12-10
DE69934902T2 (de) 2007-10-18
KR20010089413A (ko) 2001-10-06
CA2349452C (en) 2009-02-10
NO20012226D0 (no) 2001-05-04
NO20012226L (no) 2001-06-12
WO2000027833A1 (fr) 2000-05-18
US20020019399A1 (en) 2002-02-14
EP1130018A1 (de) 2001-09-05
CN1325391A (zh) 2001-12-05
ES2281196T3 (es) 2007-09-16
CA2349452A1 (en) 2000-05-18
NO321735B1 (no) 2006-06-26
EP1130018B1 (de) 2007-01-17
CN1131221C (zh) 2003-12-17

Similar Documents

Publication Publication Date Title
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
DE60016271D1 (de) Medikamentenzuführvorrichtung
IS5425A (is) Læknislyf
DE69923095D1 (de) Kostengünstige stiftförmige Medikamentenspritze
DE60014279D1 (de) Stiftförmige Medikamentenspritze
DE60011853D1 (de) Injektionsspritze
FI991485A0 (fi) Uusi farmaseuttinen koostumus
DK1223997T3 (da) Medicinsk infusionssæt
DE50002776D1 (de) Fungizide wirkstoffkombinationen
ID29089A (id) Sediaan farmasi moksifloksasin
NO20015175L (no) Farmasöytisk sammensetning
DE60033176D1 (de) Medikamentspender
NO20004196D0 (no) Innretninger for legemiddelavlevering
NO20014490L (no) Medisinske blandinger
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
DE69919784D1 (de) Spritze
NO20005179D0 (no) Medikament behandling
NO20022606L (no) Farmasöytiske kombinasjoner
NO20014926L (no) Farmasöytiske forbindelser
ID30032A (id) Formulasi farmasi
DE69934902D1 (de) Medikament gegen drogenabhängigkeit
DE50007895D1 (de) Fungizide wirkstoffkombinationen
FI4488U1 (fi) Farmaseuttinen koostumus
IS6163A (is) Lyfjakomplex

Legal Events

Date Code Title Description
8364 No opposition during term of opposition